{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T13:48:08Z","timestamp":1777556888028,"version":"3.51.4"},"reference-count":32,"publisher":"SAGE Publications","issue":"3","license":[{"start":{"date-parts":[[2022,12,13]],"date-time":"2022-12-13T00:00:00Z","timestamp":1670889600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Roche Diabetes Care GmbH, Mannheim, Germany"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["J Diabetes Sci Technol"],"published-print":{"date-parts":[[2024,5]]},"abstract":"<jats:p>Self-monitoring of blood glucose is a key aspect of diabetes management. Depending on the technology used, however, various substances can jeopardize the reliability of the measurements and precipitate complications with potentially life-threatening consequences when blood glucose was deemed well-controlled. As such, it is important for all involved to be aware of those factors. Officially suggested procedures for testing and alternatives have each their own advantages and limitations, and interferences may be found beyond the substances to be tested provided by the various pertinent institutions. This article reviews these pros and cons and illustrates how interference testing beyond established standards contributes to patient safety. Once identified, interfering substances are included in product labeling and healthcare professionals and users need to be trained to be aware of these risks.<\/jats:p>","DOI":"10.1177\/19322968221140420","type":"journal-article","created":{"date-parts":[[2022,12,13]],"date-time":"2022-12-13T23:58:23Z","timestamp":1670975903000},"page":"727-732","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":11,"title":["Drug Interference in Self-Monitoring of Blood Glucose and the Impact on Patient Safety: We Can Only Guard Against What We Are Looking for"],"prefix":"10.1177","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0316-7346","authenticated-orcid":false,"given":"Oliver","family":"Hauss","sequence":"first","affiliation":[{"name":"Dr. Hauss Training & Consulting, Maxdorf, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rolf","family":"Hinzmann","sequence":"additional","affiliation":[{"name":"Roche Diabetes Care GmbH, Mannheim, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian","family":"Huffman","sequence":"additional","affiliation":[{"name":"Roche Diabetes Care, Inc, Indianapolis, IN, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2022,12,13]]},"reference":[{"key":"bibr1-19322968221140420","doi-asserted-by":"publisher","DOI":"10.1177\/193229681100500630"},{"key":"bibr2-19322968221140420","doi-asserted-by":"publisher","DOI":"10.2337\/dc10-1732"},{"key":"bibr3-19322968221140420","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/eht108"},{"key":"bibr4-19322968221140420","doi-asserted-by":"publisher","DOI":"10.1177\/193229681300700225"},{"key":"bibr5-19322968221140420","doi-asserted-by":"publisher","DOI":"10.2337\/dc13-0092"},{"key":"bibr6-19322968221140420","unstructured":"International Diabetes Federation, ed. Recommendations for managing type 2 diabetes in primary care [Internet]. Published 2017. https:\/\/www.idf.org\/our-activities\/advocacy-awareness\/resources-and-tools\/128:idf-clinical-practice-recommendations-for-managing-type-2-diabetes-in-primary-care.html."},{"key":"bibr7-19322968221140420","doi-asserted-by":"publisher","DOI":"10.1177\/1932296817719290"},{"key":"bibr8-19322968221140420","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2018.09.002"},{"key":"bibr9-19322968221140420","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2021.109070"},{"key":"bibr10-19322968221140420","doi-asserted-by":"publisher","DOI":"10.2174\/1573399815666190215120435"},{"key":"bibr11-19322968221140420","doi-asserted-by":"publisher","DOI":"10.3349\/ymj.2013.54.5.1289"},{"key":"bibr12-19322968221140420","doi-asserted-by":"publisher","DOI":"10.1111\/dme.12497"},{"key":"bibr13-19322968221140420","doi-asserted-by":"publisher","DOI":"10.1007\/s13300-020-00838-6"},{"key":"bibr14-19322968221140420","unstructured":"Clinical and Laboratory Standards Institute, ed. Interference Testing in Clinical Chemistry (CLSI Guideline EP07). 3rd ed. Wayne, PA: Clinical and Laboratory Standards Institute; 2018. https:\/\/clsi.org\/standards\/products\/method-evaluation\/documents\/ep07\/. Accessed August 28, 2021."},{"key":"bibr15-19322968221140420","unstructured":"International Organization for Standardization. ISO 15197:2013 [Internet]. International Organization for Standardization; 2013. http:\/\/www.iso.org\/cms\/render\/live\/en\/sites\/isoorg\/contents\/data\/standard\/05\/49\/54976.html. Accessed December 17, 2018."},{"key":"bibr16-19322968221140420","doi-asserted-by":"publisher","DOI":"10.1177\/193229681100500507"},{"key":"bibr17-19322968221140420","doi-asserted-by":"publisher","DOI":"10.1177\/1932296821999416"},{"key":"bibr18-19322968221140420","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinbiochem.2021.03.007"},{"key":"bibr19-19322968221140420","doi-asserted-by":"publisher","DOI":"10.1177\/19322968211041328"},{"key":"bibr20-19322968221140420","volume-title":"Clinical Laboratory Diagnostics Use and Assessment of Clinical Laboratory Results","author":"Thomas L","year":"1998"},{"key":"bibr21-19322968221140420","doi-asserted-by":"publisher","DOI":"10.1177\/19322968211042352"},{"key":"bibr22-19322968221140420","doi-asserted-by":"publisher","DOI":"10.1177\/1932296819873053"},{"key":"bibr23-19322968221140420","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.23.8.1143"},{"key":"bibr24-19322968221140420","unstructured":"US Food & Drug Administration, ed. Self-monitoring blood glucose test systems for over-the-counter use [Internet]. https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/self-monitoring-blood-glucose-test-systems-over-counter-use. Published 2021. Accessed March 20, 2022."},{"key":"bibr25-19322968221140420","unstructured":"Clinical and Laboratory Standards Institute. EP07 Supplement (EP37) Supplemental Tables for Interference Testing in Clinical Chemistry. 1st ed. Wayne, PA: Clinical and Laboratory Standards Institute; 2018. https:\/\/clsi.org\/standards\/products\/method-evaluation\/documents\/ep07-supplement\/. Accessed October 6, 2022."},{"key":"bibr26-19322968221140420","unstructured":"American Association for Clinical Chemistry. Effects on clinical laboratory tests. drugs, disease, herbs and natural products. https:\/\/clinfx.wiley.com\/aaccweb\/aacc\/login. Published 2013. Accessed October 8, 2021."},{"key":"bibr27-19322968221140420","volume-title":"Effects of Drugs on Clinical Laboratory Tests","author":"Young DS.","year":"2000"},{"key":"bibr28-19322968221140420","volume-title":"Effects of Disease on Clinical Laboratory Tests","author":"Young DS","year":"2001"},{"key":"bibr29-19322968221140420","volume-title":"Effects of Herbs and Natural Products on Clinical Laboratory Tests","author":"Narayanan S","year":"2007"},{"key":"bibr30-19322968221140420","doi-asserted-by":"publisher","DOI":"10.1177\/19322968211050370"},{"key":"bibr31-19322968221140420","unstructured":"Medline Industries, Inc., ed. EvenCare G2 clinical results and performance data [Internet].https:\/\/www.medline.com\/media\/mkt\/pdf\/EvenCare-Lit928-EvenCare-G2-Clinical-Data.pdf. Published 2011. Accessed October 8, 2021."},{"key":"bibr32-19322968221140420","doi-asserted-by":"publisher","DOI":"10.1177\/19322968221095573"}],"container-title":["Journal of Diabetes Science and Technology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/19322968221140420","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/19322968221140420","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/19322968221140420","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T18:16:13Z","timestamp":1777400173000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/19322968221140420"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,13]]},"references-count":32,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["10.1177\/19322968221140420"],"URL":"https:\/\/doi.org\/10.1177\/19322968221140420","relation":{},"ISSN":["1932-2968","1932-2968"],"issn-type":[{"value":"1932-2968","type":"print"},{"value":"1932-2968","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,13]]}}}